MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The care needs project: Understanding the experience of people with Parkinson’s in institutional care and understanding the care needs of people with Parkinson’s

    A. Hand, R.W. Walker, W.K. Gray, L.L. Oates (North Shields, United Kingdom)

    Objective: To look at predictors to care home placement for people with Parkinson's (PD) along with the experience of those already in care and identify…
  • 2016 International Congress

    Influence of vibration to quality of life of patients with Parkinson’s disease

    V. Rashidov (Tashkent, Uzbekistan)

    Objective: To study influence of vibration at the Qizil tosh marble manufacture in Tashkent City. Background: A marble is a small spherical toy usually made…
  • 2016 International Congress

    Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment

    G. Amorelli, L.F. Vasconcellos, M. Spitz, L.F. Fraga (Rio de Janeiro, Brazil)

    Objective: To trace a clinical and epidemiological profile of patients treated with botulinum toxin, evaluating the impact on quality of life. Background: The Botulinum Toxin…
  • 2016 International Congress

    Preliminary results for a study on quality of life in Huntington’s disease patients and their caregivers in Peru

    A. Vishnevetsky, M.A. Inca-Martinez, M. Illanes-Manrique, M. Cornejo-Olivas (Lima, Peru)

    Objective: To quantitatively and qualitatively explore the determinants of quality of life (QOL) in Huntington's Disease (HD) patients and their caregivers in Peru. Background: HD…
  • 2016 International Congress

    Impact of self-efficacy education on physical and psychosocial functioning in newly-diagnosed Parkinson patients

    D. Cook, C. McRae, R. Kumar (Englewood, CO, USA)

    Objective: To evaluate whether this program improves physical and psychosocial functioning in newly-diagnosed persons with Parkinson's disease (PWP) over the 12-month period of the intervention…
  • 2016 International Congress

    The effect of a structured medication review on quality of life in patients with Parkinson’s disease. An interim analysis

    A. Verbeek, N. Oonk, E. Munster, K. Movig, K. ter Huurne, H. Nijmeijer, J. van der Palen, L. Dorresteijn (Eerbeek, Netherlands)

    Objective: To investigate whether a structured medication review executed by a community pharmacist improves medication adherence and influences quality of life in patients with Parkinson's…
  • 2016 International Congress

    The association between objectively measured physical activity and health-related-quality of life in people with Parkinson’s disease

    J.M.T. Van Uem, I. Liepelt-Scarfone, B. Cerff, M. Kampmeyer, J. Prinzen, M. Zuidema, M.A. Hobert, S. Hucker, S. Del Din, S. Gräber, D. Berg, W. Maetzler (Tübingen, Germany)

    Objective: To evaluate the association between a large number of objectively measured parameters of physical activity in the domestic environment using wearable sensors and Health-Related-Quality…
  • 2016 International Congress

    My PD Journey: Experiences reported by people with Parkinson’s disease in several European countries – A quantitative and qualitative study

    A. Schrag, O. Rascol, R. Merritt, S. Hotham, G. Bartl, L. Graham, On behalf of the European Parkinson's Disease Association (EPDA) and the Movement Disorder Society- European Section European Section (London, United Kingdom)

    Objective: To document experience of service provision by people with Parkinson's disease (PD) care in Europe. Background: Developed by the EPDA, My PD Journey is…
  • 2016 International Congress

    Broadening the evaluative scope of quality of life in Parkinson’s: Testing the construct validity of the ICECAP-O instrument

    Y. Xin, J. Lewsey, R. Gray, C.E. Clarke, E. McIntosh (Glasgow, United Kingdom)

    Objective: To test the construct validity of ICECAP-O in Parkinson's and explore its relationship with the EQ-5D and the PDQ-39. Background: Parkinson's significantly affects patients'…
  • 2016 International Congress

    Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm

    B. Yuksel, F. Genc, A. Yaman, P. Dogan Ak, E. Ozaydin Goksu, A. Aybar, Y. Bicer Gomceli (Antalya, Turkey)

    Objective: Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial…
  • « Previous Page
  • 1
  • …
  • 1577
  • 1578
  • 1579
  • 1580
  • 1581
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley